Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at PLN 107.9B, ahead of Eli Lilly (PLN 83.1B) and Merck & Co (PLN 73.5B). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonPLN 107.9B
- Median
- PLN 237.4M
- Combined market value
- PLN 20.47T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 107.9B | PLN 2.67T | PLN 1,109.60 | 1.05% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 83.1B | PLN 4.97T | PLN 5,579.51 | 2.04% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 73.5B | PLN 1.39T | PLN 561.88 | 2.60% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | PLN 61.2B | PLN 701.2B | PLN 159.10 | 2.85% down | 17% down | ||
| 5 | NovartisNVS · Health Care | PLN 56.3B | PLN 1.18T | PLN 627.39 | 2.02% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 41.1B | PLN 1.12T | PLN 721.47 | 1.63% down | 2% up | ||
| 7 | SanofiSNY · Health Care | PLN 34.9B | PLN 457.2B | PLN 190.39 | 0.45% down | 4% down | ||
| 8 | PfizerPFE · Health Care | PLN 31.3B | PLN 646.4B | PLN 113.41 | 1.00% down | 14% up | ||
| 9 | GSKGSK · Health Care | PLN 30.5B | PLN 393.5B | PLN 196.32 | 0.91% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | PLN 28.4B | PLN 495.2B | PLN 242.27 | 1.86% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 26.3B | PLN 731.3B | PLN 422.26 | 0.22% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | PLN 18.1B | PLN 398.1B | PLN 3,848.18 | 0.15% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | PLN 17B | PLN 2.06T | PLN 1,163.44 | 1.26% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | PLN 15.9B | PLN 546.1B | PLN 2,153.82 | 0.20% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | PLN 10.8B | PLN 137.3B | PLN 337.86 | 0.58% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 5.7B | PLN 198.4B | PLN 170.05 | 0.84% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | PLN 5.4B | PLN 99.2B | PLN 2,328.29 | 0.94% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | PLN 3.9B | PLN 127B | PLN 206.02 | 1.46% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | PLN 3.1B | PLN 159.3B | PLN 277.08 | 0.26% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | PLN 2.7B | PLN 20.3B | PLN 242.84 | 0.02% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 1.8B | PLN 50.3B | PLN 60.30 | 1.32% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | PLN 1.8B | PLN 39.7B | PLN 262.67 | 4.10% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | PLN 1.8B | PLN 23.3B | PLN 34.26 | 1.33% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | PLN 1.4B | PLN 47B | PLN 242.59 | 3.04% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | PLN 1.3B | PLN 81.7B | PLN 610.07 | 3.12% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | PLN 1.2B | PLN 185.3B | PLN 1,621.83 | 2.47% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | PLN 972.4M | PLN 31.6B | PLN 187.79 | 2.68% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | PLN 500.8M | PLN 24.2B | PLN 1,207.74 | 2.16% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | PLN 401M | PLN 30B | PLN 273.82 | 2.88% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | PLN 289.9M | PLN 30.2B | PLN 86.73 | 2.06% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 237.4M | PLN 30.3B | PLN 386.22 | 0.92% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -PLN 6.6M | PLN 24.5B | PLN 173.10 | 0.07% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -PLN 94M | PLN 24B | PLN 367.98 | 0.54% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -PLN 102.8M | PLN 19.4B | PLN 202.42 | 1.56% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -PLN 281.6M | PLN 21.1B | PLN 499.21 | 1.25% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -PLN 312.3M | PLN 25.8B | PLN 636.28 | 0.26% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -PLN 424.2M | PLN 26.3B | PLN 388.26 | 0.18% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -PLN 501.1M | PLN 18.5B | PLN 52.75 | 5.62% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -PLN 523.7M | PLN 32.9B | PLN 504.62 | 0.59% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -PLN 624.5M | PLN 36.5B | PLN 383.87 | 1.69% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -PLN 653.2M | PLN 19.7B | PLN 348.96 | 0.29% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -PLN 675.2M | PLN 18.2B | PLN 165.78 | 2.00% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -PLN 737.1M | PLN 28.3B | PLN 538.95 | 1.48% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -PLN 739.5M | PLN 15.7B | PLN 115.00 | 2.72% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -PLN 790.8M | PLN 32.7B | PLN 471.07 | 0.39% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -PLN 933.5M | PLN 53.2B | PLN 106.47 | 2.36% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -PLN 1B | PLN 71.5B | PLN 1,090.73 | 0.04% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -PLN 1.2B | PLN 37.9B | PLN 1,631.53 | 3.91% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -PLN 1.2B | PLN 12.7B | PLN 65.31 | 0.74% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -PLN 1.2B | PLN 112.2B | PLN 154.80 | 0.62% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -PLN 1.2B | PLN 34.3B | PLN 1,228.83 | 0.11% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -PLN 1.3B | PLN 19.8B | PLN 113.69 | 1.45% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -PLN 1.4B | PLN 63.1B | PLN 982.31 | 1.42% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -PLN 1.5B | PLN 29.5B | PLN 336.43 | 1.84% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -PLN 1.5B | PLN 18.4B | PLN 110.29 | 1.67% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -PLN 2.9B | PLN 60.9B | PLN 312.45 | 1.11% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -PLN 3.2B | PLN 28.7B | PLN 206.20 | 0.78% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -PLN 3.8B | PLN 274.8B | PLN 86.01 | 1.22% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -PLN 4.3B | PLN 34.1B | PLN 42.69 | 0.56% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -PLN 5.1B | PLN 106.2B | PLN 484.04 | 1.28% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -PLN 14.1B | PLN 94.9B | PLN 82.75 | 0.56% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0238 PLN).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (PLN 107.9B), Eli Lilly (PLN 83.1B) and Merck & Co (PLN 73.5B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of PLN 20.47T as of 18 Nov 2026, 16:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.